Views & Analysis Will plausibility reign supreme in Lyrica second medical use... Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.
Events Partner Content 2018 Off-Label Regulatory Compliance Congress Explore the Ever-Changing Regulatory Landscape
Events Partner Content Responding to the Opioid Crisis: Litigation, Regulation &... There are numerous pharmaceutical and plaintiff conferences on the opioid crisis, but none that cover the legal and regulatory aspects from BOTH sides of litigation.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
